Rafael Blesa - Sant Pau Memory Unit - Alzheimer Research - Barcelona

Rafael Blesa

Rafael Blesa GonzalezDr. Rafael Blesa obtained his medical degree from the Universitat Autònoma de Barcelona in 1975 and specialized in Neurology at Hospital de la Santa Creu i Sant Pau.

After completing his Ph.D. in Medicine at the Universitat de Barcelona (1989) he worked at the National Institute of Health in Bethesda, Maryland (USA) as an associate researcher in experimental therapies. He returned to Barcelona in 1993 where he directed the Alzheimer and Other Cognitive Disorders Unit at Hospital Clínic for 10 years. Since 2003, Dr Blesa has been the Director of the Neurology Department at Hospital de la Santa Creu i Sant Pau.

Dr. Rafael Blesa is the author of more than 30 book chapters and more than 170 scientific articles published in high impact national and international journals, and he has been the principal investigator of over 70 research projects and pharmacological studies in the field of Alzheimer’s disease. He is a member of prestigious medical and scientific societies that have awarded his scientific contributions in numerous occasions.

In his professional trajectory, he has combined clinical and research tasks with teaching activities as an associate professor of Neurology at Universitat de Barcelona and Universitat Autònoma de Barcelona, and he has directed and supervised numerous doctoral theses.

Currently, besides directing the Neurology Department, Dr. Rafael Blesa is the principal investigator of the advanced therapies research line within the Memory Unit.


Recent Publications

  1. Liberation and Micellarization of Carotenoids from Different Smoothies after Thermal and Ultrasound Treatments. Buniowska, M et al. Foods 2019

  2. New tracheal stainless steel stent pilot study: twelve month follow-up in a rabbit model. Lopez-Minguez, S et al. PeerJ 2019

  3. Comment on: "Efficacy and Safety of Supportive Care Biosimilars Among Cancer Patients: A Systematic Review and Meta-Analysis". Puértolas-Tena, I et al. BioDrugs 2019

  4. Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Garrido, P et al. Clin Transl Oncol 2019

  5. Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease. Chaparro, M et al. Therap Adv Gastroenterol 2019

  6. Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination. Garcés, JJ et al. Leukemia 2019

  7. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH). Crespo, J et al. Gastroenterol Hepatol 2019

  8. Nailfold capillaroscopy in the Spanish Group of Systemic Autoimmune Diseases (GEAS). Results of an electronic survey. Sáez-Comet, L et al. Med Clin (Barc) 2019

  9. T-Cell-Rich Recurrence of Primary Cutaneous Follicle Center Lymphoma After Systemic Rituximab: A Diagnostic Pitfall. Santonja, C et al. Am J Dermatopathol 2019

  10. Serotonergic innervation of the striatum in a nonhuman primate model of Parkinson's disease. Jiménez-Sánchez, L et al. Neuropharmacology 2019

  11. Methods to Identify and Analyze Vesicle-Protected DNA Transfer. Blesa, A et al. Methods Mol. Biol. 2020

  12. [Agression to health care personnel in Spain: a systematic review]. Serrano Vicente, MI et al. Rev. Esp. Salud Publica 2019

  13. Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer. Ciruelos, EM et al. Eur J Cancer Care (Engl) 2019

  14. Analysis of the postoperative hemostatic profile of colorectal cancer patients subjected to liver metastasis resection surgery. Perez Navarro, G et al. World J Clin Cases 2019

  15. Role of Adherence to Enhanced Recovery After Surgery Programs in Mitigating Healthcare Disparities-Reply. Ripollés-Melchor, J et al. JAMA Surg 2019

Search PubMed